Inventor · disambiguated record
Tamar Lotan
Also filed as: LOTAN TAMAR
19 granted patents·5 pending applications·305 citations·filing 1995–2015
95Inventor score
Top patents by PatentIndex Score
24 records- 0191US6613344B2Methods utilizing stinging cells/capsulesNANOCYTE INC·Filed 2001·Granted Sep 2, 2003·31 cites·25 claims
- 0290US6781035B1Leafy cotyledon1 genes and their usesUNIV CALIFORNIA·Filed 2000·Granted Aug 24, 2004·36 cites·26 claims
- 0388US6923976B2Methods compositions and devices utilizing stinging cells/capsules for delivering therapeutic or a cosmetic agent into a tissueFiled 2003·Granted Aug 2, 2005·20 cites·23 claims
- 0487US8287912B2Use of stinging cells/capsules for the delivery of active agents to keratinous substancesLOTAN TAMAR·Filed 2011·Granted Oct 16, 2012·4 cites·6 claims
- 0587US8062660B2Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissueLOTAN TAMAR·Filed 2006·Granted Nov 22, 2011·7 cites·15 claims
- 0684US7998509B2Use of stinging cells/capsules for the delivery of active agents to keratinous substancesNANOCYTE INC·Filed 2009·Granted Aug 16, 2011·5 cites·22 claims
- 0783US6235975B1Leafy cotyledon1 genes and methods of modulating embryo development in transgenic plantsUNIV CALIFORNIA·Filed 1998·Granted May 22, 2001·57 cites·39 claims
- 0882US7632522B2Use of stinging cells/capsules for the delivery of active agents to keratinous substancesNANOCYTE INC·Filed 2006·Granted Dec 15, 2009·4 cites·12 claims
- 0981US8337868B2Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissueLOTAN TAMAR·Filed 2009·Granted Dec 25, 2012·2 cites·15 claims
- 1081US5965795APolynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a beta-C-4-oxygenase activity for biotechnological production of (3S, 3'S) astaxanthin and its specific expression in chromoplasts of higher plantsYISSUM RES DEV CO·Filed 1996·Granted Oct 12, 1999·36 cites·17 claims
- 1179US7338665B2Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissueNANOCYTE INC·Filed 2004·Granted Mar 4, 2008·8 cites·16 claims
- 1276US7611723B2Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissueNANOCYTE INC·Filed 2003·Granted Nov 3, 2009·6 cites·20 claims
- 1375US5916791APolynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a β--C--4--oxygenase activity for biotechnological production of (3S,3S)astaxanthinFiled 1995·Granted Jun 29, 1999·24 cites·2 claims
- 1473US6320102B1Leafy cotyledon1 genes and their usesUNIV CALIFORNIA·Filed 1998·Granted Nov 20, 2001·31 cites·9 claims
- 1571US6218599B1Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a β-C-4-oxygenase activity for biotechnological production of (3S, 3'S) astaxanthin and its specific expression in chromoplasts of higher plantsYISSUM RES DEV CO·Filed 1999·Granted Apr 17, 2001·18 cites·15 claims
- 1667US6545201B1Leafy cotyledon1 genes and their usesUNIV CALIFORNIA·Filed 1998·Granted Apr 8, 2003·16 cites·13 claims
- 1763US2014322290A1Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agentNANOCYTE INC·Filed 2014·Application pending·0 cites
- 1859US8834862B2Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agentLOTAN TAMAR·Filed 2005·Granted Sep 16, 2014·0 cites·6 claims
- 1957US8486441B2Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissueLOTAN TAMAR·Filed 2010·Granted Jul 16, 2013·0 cites·19 claims
- 2057US6903245B2Polynucleotide molecule from haematococcus pluvialis encoding a polypeptide having a ⊕-c-4-oxygenase activity for biotechnological production of (3s,3's) astaxanthin and its specific expression in chromoplasts of higher plantsYISSUM RES DEV CO·Filed 2001·Granted Jun 7, 2005·0 cites·9 claims
- 2156US2006099272A1Compositions and kits including dehydrated stinging capsules and methods of producing and using sameNANOCYTE INC·Filed 2004·Application pending·0 cites
- 2256US2007281037A9Sterile preparations and compositions including stinging capsules and methods of producing and using sameNANOCYTE INC·Filed 2004·Application pending·0 cites
- 2352US2013216603A1Pharmaceutical compositions and delivery devices comprising stinging cells or capsulesECKHOUSE SHIMON·Filed 2011·Application pending·0 cites
- 2447US2015250714A1Pharmaceutical compositions and delivery devices comprising stinging cells or capsulesNANOCYTE ISRAEL LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tamar Lotan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →